Eliseu O. De Oliveira, Ph.D. - Publications
Affiliations: | VCU School of Engineering |
Area:
API process development, organic synthesis, medicinal chemistry, flow chemistry, heterocyclic chemistry, drug discovery, drug development, CNS, cancer, inflammation, pain, COPD,Website:
https://egr.vcu.edu/directory/eliseudeoliveira/Year | Citation | Score | |||
---|---|---|---|---|---|
2017 | Nathan S, Ma Y, Tomita YA, De Oliveira E, Brown ML, Rosen EM. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells. Breast Cancer Research and Treatment. PMID 28808806 DOI: 10.1007/S10549-017-4442-Y | 0.506 | |||
2015 | Ma Y, Preet A, Tomita Y, De Oliveira E, Zhang L, Ueda Y, Clarke R, Brown M, Rosen EM. A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance. Oncotarget. PMID 26575173 DOI: 10.18632/Oncotarget.6323 | 0.466 | |||
2014 | Ma Y, Tomita Y, Preet A, Clarke R, Englund E, Grindrod S, Nathan S, De Oliveira E, Brown ML, Rosen EM. Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α. Molecular Endocrinology (Baltimore, Md.). 28: 1971-86. PMID 25264941 DOI: 10.1210/Me.2014-1146 | 0.495 | |||
2011 | De Oliveira EO, Graf KM, Patel MK, Baheti A, Kong HS, MacArthur LH, Dakshanamurthy S, Wang K, Brown ML, Paige M. Synthesis and evaluation of hermitamides A and B as human voltage-gated sodium channel blockers. Bioorganic & Medicinal Chemistry. 19: 4322-9. PMID 21683602 DOI: 10.1016/J.Bmc.2011.05.043 | 0.346 | |||
Show low-probability matches. |